Trump Vows to Force European Countries to Pay Higher Drug Prices

President Donald Trump has threatened European countries that they must pay higher drug prices or face trade sanctions, while vowing to cut US drug prices by as much as 80 per cent. Speaking at the White House, Trump stated his administration would punish countries that refuse to "equalise" their medicines prices with the US or that "extort" drug companies into lowering their charges. This move opens a new conflict with US trading partners following Trump's "liberation day" tariffs imposed across the world last month.

The US pays about 3.2 times more for branded drugs than other developed countries in 2022, according to research by Rand healthcare for the country's health and human services department. Trump's plan is met with opposition from the US biotech industry, which has called it akin to "importing socialised medicine." Analysts warn that Trump's proposal faces a similar struggle to his previous attempts at price controls.

Key Takeaways:

• President Trump has threatened to impose trade sanctions on European countries that do not agree to "equalise" their medicines prices with the US.
• The US pays significantly higher prices for branded drugs compared to other developed countries, with a 3.2 times higher price index in 2022.
• Trump's plan aims to cut US drug prices by as much as 80 per cent, while forcing European countries to pay higher prices.
• The US biotech industry has strongly opposed Trump's proposal, calling it akin to "importing socialised medicine."
• Trump's plan faces a similar struggle to his previous attempts at price controls, which were defeated in court.
• The US Trade Representative and Department of Commerce will probe nations that "extort" drug companies by blocking their products unless they accept low dollar amounts.
• Trump's executive order will "communicate price targets to pharmaceutical manufacturers" and cut out "middlemen" allowing patients to buy directly from manufacturers.
• The goal of the proposal is to reduce US drug prices to the lowest price available worldwide.

Statistics:

• The US paid about 3.2 times more for branded drugs than other developed countries in 2022, according to research by Rand healthcare.
• Trump's proposal aims to cut US drug prices by as much as 80 per cent.
• The Biotechnology Innovation Organization has stated that patients and families are being treated as a "bargaining chip in a trade war."

Sources:

• This article is based on a report from Patrick Temple-West in New York and Michael Peel in London.
• Rand healthcare research quoted in the article.
• Biotechnology Innovation Organization (exact reference needed).